A growing body of evidence on the latest round of vaccines deployed against the African swine fever (ASF) virus suggests these vaccines are increasingly effective in preventing pigs from dying from the disease, but that some questions around safety persist, according to a research review paper from Jeonbuk National University in South Korea.
That a growing number of countries are testing potential vaccines “signals that ASF vaccine development is no longer in its infancy; we are approaching the stage of early deployment,” Gayeon Won, an associate professor of veterinary public health and food safety at Jeonbuk National University, said. “However, safety, long-term stability and international regulatory acceptance remain critical barriers before widespread commercial use can occur.”
